Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

It’s a multidisciplinary approach, often termed ‘synbio’, that involves redesigning organisms – including through ‘plug and play’ combinations of pathways for drug design and ...